Immunological enhancement of stem cell activity in treatment of ovarian failure
T Ichim, A Patel, C Bartlett - US Patent App. 18/311,457, 2023 - Google Patents
Disclosed are methods, protocols and compositions of matter using for treatment of ovarian
failure through administration of cells expressing FoxP3 as a monotherapy or as a facilitator …
failure through administration of cells expressing FoxP3 as a monotherapy or as a facilitator …
Enhancement of umbilical cord mesenchymal stem cell therapeutic activity by stimulators of t regulatory cells and/or cells expressing cd73
C Thomas, F Ramos, J Veltmeyer, TG Dixon… - US Patent App. 17 …, 2023 - Google Patents
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C ([C@ H](NC (=
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …
O)[C@ H](C (C) C) NC (= O) CNC (= O)[C@ H](CCC (O)= O) NC (= O)[C@ H](CCCNC (N) …
Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cells
TE Ichim, F Ramos, J Veltmeyer, TG Dixon… - US Patent …, 2024 - Google Patents
2023-03-12 Assigned to THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. reassignment
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. ASSIGNMENT OF ASSIGNORS …
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. ASSIGNMENT OF ASSIGNORS …
Fibroblast based therapeutics of amyotrophic lateral sclerosis
T Ichim, P O'heeron - US Patent App. 18/570,530, 2024 - Google Patents
The present disclosure concerns methods and compositions for treating or preventing or
reducing the risk of having Amyotrophic Lateral Sclerosis (ALS) in an individual. In particular …
reducing the risk of having Amyotrophic Lateral Sclerosis (ALS) in an individual. In particular …
Protection from ovarian failure by low dose interleukin-2 administration
T Ichim, A Patel, C Bartlett - US Patent App. 18/311,464, 2023 - Google Patents
Disclosed are compositions of matter, protocols and procedures useful for
preventing/treatment ovarian failure. In one embodiment cytokines promoting anti …
preventing/treatment ovarian failure. In one embodiment cytokines promoting anti …
Treatment of major depressive disorder by low dose interleukin-2
TE Ichim, TG Dixon, K O'connor… - US Patent App. 17 …, 2022 - Google Patents
Preferred embodiments are directed to methods directed to the treatment of major
depressive disorder com prising enhancing the numbers and/or activity of T regula tory …
depressive disorder com prising enhancing the numbers and/or activity of T regula tory …